The Times Can a five-day diet save your life?One million people may be living with type 2 diabetes without knowing it. Peta Bee evaluates fasting diets that claim to reduce …
Diabetes
-
Diet
-
ethical approval This study was reviewed and approved by the Biomedical Research Ethics Committee of the Province of Granada (CEIm/CEI GRANADA). Protocol Code: K134665CRL, Ethics Portal Code: 0698-N-21. Data has …
-
Education
The number of students developing diabetes is increasing.What this means for the classroom
The number of American schoolchildren managing diabetes continues to grow, and experts predict that by 2060, more than 500,000 will suffer from the chronic health condition. This means that educators …
-
Type 1
Study finds that rising drug costs are a barrier to diabetes treatment
by News Sourceby News SourceActively managing diabetes is essential to prevent long-term health complications, but rising costs are a barrier to treatment. According to the Centers for Disease Control and Prevention, diabetes is now …
-
Type 2 diabetes medications include Glucophage (metformin), sulfonylureas, alpha-glucosidase inhibitors, and other medications that change the way your body uses insulin and glucose. Not everyone with type 2 diabetes needs …
-
Emotional Effects
The health burden of diabetes negatively impacts the quality of life of elderly patients
by Sandra Fyfeby Sandra FyfeUnderstanding diabetes, a common chronic disease in adults over 65, and its impact on quality of life (QoL) may reduce the burden on health and lead to better management and …
-
Every day, more than 6000 children and young adults in Georgia with diabetes go to school, play sports, have friends and do …
-
General Health
What is the real cause of diabetes? Your Diabestie Episode 11 » Hungry Woman®
by News Sourceby News Sourceshare In this episode of Your Diabestie, Mila discussed the multifaceted nature of diabetes, including its causes and symptoms, and highlighted the different types of diabetes and their management strategies. …
-
Oramed hopes the upcoming Phase 3 trial will be even more successful. Image credit: Getty Images / Karl Tapales. oramed pharmaceutical announced that it is considering restarting a Phase 3 …
-
Type 2
Non-alcoholic fatty liver disease increases cardiovascular disease and mortality risk in patients with diabetes
1. The risk of cardiovascular disease (CVD) and all-cause mortality in patients with type 2 diabetes mellitus (T2DM) is increased in patients with nonalcoholic fatty liver disease (NAFLD). compared with …